provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content
HomeDrugsStrattera

How Long Does Strattera Take to Work? Learn Answers to 6 Strattera FAQs

Alex Brewer, PharmD, MBATegan Smedley, PharmD, APh
Published on July 1, 2024

Key takeaways:

  • Strattera (atomoxetine) is a prescription-only medication that’s FDA approved to treat attention-deficit hyperactivity disorder (ADHD) in adults and children age 6 and older. Unlike many ADHD medications, Strattera isn’t a controlled substance.

  • Though Strattera may start working for ADHD symptoms in as little as 1 week for some people, it typically takes about 4 to 8 weeks to feel the effects. You may also find that the medication is more effective with long-term treatment (1 year or longer).

  • Strattera is available as a lower-cost generic. GoodRx may be able to help you save over 90% off the average retail price of Strattera at certain pharmacies.

A child is at a counseling session.
Phynart Studio/E+ via Getty Images

Medications that treat attention-deficit hyperactivity disorder (ADHD) can be broadly split into two categories: stimulants and nonstimulants. Stimulants are the most popular medications for treating ADHD in both children and adults. They work well, act fast, and have been used safely for many decades. But stimulants come with a risk of dependence and misuse. So some people may prefer to take a nonstimulant ADHD medication. 

Strattera (atomoxetine) is one example. It works differently from stimulant medications and doesn’t have a known risk for dependence. These factors could make it a good option if you’re worried about stimulant side effects or misuse.

It’s normal to have questions about Strattera, especially if you or your child has just been prescribed the medication. For example, many people wonder how long Strattera takes to work and whether it’s a controlled substance. Below, you’ll find answers to six frequently asked questions about the medication, which you can combine with information from your prescriber and pharmacist.

Promotion disclosure
Avg retail price
$426.99(Save 93.96%)
GoodRx discount
$25.79
How it works
drug-savings-illustration-1Use GoodRx to find medications, pharmacies, and discounts.
drug-savings-illustration-2GoodRx discounts can help you pay less for your prescription.
drug-savings-illustration-3Bring your free coupon or savings card to the pharmacy.

1. How long does Strattera take to work?

Some people may notice a decrease in their ADHD symptoms as soon as 1 week after starting treatment with Strattera. But for most people, it takes about 4 to 8 weeks to feel the medication’s full effects. You may also notice that it’s more effective the longer you take it. In studies, people were more likely to experience success with long-term Strattera treatment (1 year or longer).

If you feel that you or your child needs a medication that works faster, you may want to discuss other ADHD medication options with your prescriber. There are other nonstimulant treatments, such as clonidine (Kapvay) and guanfacine (Intuniv), that start working within a few hours. Your prescriber can make recommendations based on your treatment goals and expectations.

GoodRx icon
  • Living with attention-deficit hyperactivity disorder (ADHD): One woman shares her tips for managing ADHD, including sticking to routines and keeping herself motivated while completing tasks.

  • The right dosage: While Strattera has a standard starting dosage, there are variables that can impact how much you should take.

  • How it works: Strattera works differently than stimulant ADHD medications such as Adderall. Read more about how Strattera works to treat ADHD symptoms.

2. How does Strattera work?

Experts don’t fully understand how Strattera works to treat ADHD. But it belongs to the norepinephrine reuptake inhibitor (NRI) class of medications. So it boosts levels of norepinephrine, a chemical messenger that plays a role in focus and concentration, in the brain. It’s thought that higher levels of norepinephrine help reduce ADHD symptoms.

Strattera may also raise dopamine levels in certain parts of the brain. Dopamine is a chemical messenger that helps regulate attention and mood, among other actions. Typically when a medication or substance boosts dopamine levels, it carries a risk for dependence. But because of where in the brain Strattera raises dopamine, this isn’t an issue.

How is Strattera different from stimulants such as Adderall?

Both Strattera and stimulants such as Adderall (mixed amphetamine salts) raise levels of norepinephrine and dopamine in the brain. But there’s a big difference in how these medications affect dopamine.

Adderall and other stimulants increase dopamine in two parts of the brain: the nucleus accumbens and the prefrontal cortex. A dopamine boost in the prefrontal cortex helps reduce ADHD symptoms. But an increase of dopamine in the nucleus accumbens acts as a reward to the brain. This can lead to substance use disorder for some people.

Strattera only triggers a dopamine boost in the prefrontal cortex. Since it doesn’t impact dopamine levels in the nucleus accumbens, it doesn’t create the same reward for the brain. That’s why Strattera doesn’t carry the risk of dependence that Adderall and other stimulants do.

3. Is Strattera a controlled substance?

No, Strattera isn’t a controlled substance. A controlled substance is a medication or substance that carries a risk of physical and mental dependence. As discussed above, Strattera isn’t known to have these risks because of how it works. Clinical studies also found that people taking Strattera are not likely to experience withdrawal symptoms when they stop treatment.

4. How long do the effects of Strattera last?

Strattera leaves the body relatively quickly. For many people, it takes about 1 day to fully clear a dose of Strattera. So if you need to stop the medication quickly, it shouldn’t take long for your body to clear it from your system.

But this doesn’t mean the effects of Strattera wear off immediately. In multiple studies, the benefits of the medication gradually wore off over about 6 months. Some people found the medication stopped working within a few weeks, while others felt its effects for a few months after stopping treatment. Similarly, Strattera side effects seem to wear off in anywhere between a few days and about 2 months.

5. Does Strattera make you gain weight?

No, Strattera doesn’t usually cause weight gain. But it’s possible you may experience weight loss as a side effect. This is because Strattera can lower some people’s appetites. But keep in mind Strattera is not a weight-loss medication and shouldn’t be taken for this purpose.

In children, Strattera can temporarily slow growth during the first 9 to 12 months of treatment. This affects both height and body weight. But studies have found that slowed growth related to Strattera isn’t permanent. Children typically catch up to where they’re supposed to be within about 2 to 3 years.

6. Is it OK to stop taking Strattera suddenly?

It’s best to talk to a healthcare professional before stopping treatment with Strattera (or any medication for ADHD). As mentioned above, it’s unlikely that you’ll experience withdrawal symptoms if you miss a dose or stop taking Strattera “cold turkey.” But your ADHD symptoms are likely to worsen or return once you stop treatment. So stopping the medication suddenly without another treatment to replace it could negatively impact your quality of life.

If you’re interested in stopping Strattera treatment, speak with your prescriber. They can help you decide the next best steps for managing your ADHD symptoms.

How to save on Strattera

There are ways to save on Strattera, which is available as both a brand-name and generic medication:

The bottom line

Strattera (atomoxetine) is a nonstimulant attention-deficit hyperactivity disorder (ADHD) medication. For some people, Strattera starts working in as little as 1 week. But for most people, it takes about 4 to 8 weeks to experience the full benefits. Long-term Strattera treatment (1 year or longer) may lead to increased symptom improvement.

Strattera isn’t a controlled substance because it doesn’t carry a risk of dependence or misuse. It’s also unlikely that the medication will cause withdrawal symptoms if treatment is stopped. However, it’s not recommended to stop treatment suddenly since ADHD symptoms can return or worsen.

why trust our exports reliability shield

Why trust our experts?

Alex Brewer, PharmD, MBA
Alex Brewer, PharmD, MBA, is a licensed pharmacist specializing in chronic disease and health and wellness. Upon completing his residency, he worked in the managed care field, conducting medication therapy management and adherence counseling sessions with Medicaid, Medicare, and private insurance patients, before transitioning to a career in medical writing.
Christina Aungst, PharmD
Christina Aungst, PharmD, is a pharmacy editor for GoodRx. She began writing for GoodRx Health in 2019, transitioning from freelance writer to editor in 2021.
Tegan Smedley, PharmD, APh
Tegan Smedley, PharmD, APh, has 10 years of experience as a pharmacist. She has worked in a variety of settings, including retail, hospital, and ambulatory care.

References

American Academy of Family Physicians. (n.d.). Treatment and management of ADHD in adults.

Bryant Ranch Prepack. (2024). Atomoxetine - atomoxetine capsule [package insert].

View All References (11)

Buitelaar, J., et al. (2015). Differences in maintenance of response upon discontinuation across medication treatments in attention-deficit/hyperactivity disorder. European Neuropsychopharmacology.

Childress A. C. (2015). A critical appraisal of atomoxetine in the management of ADHD. Therapeutics and Clinical Risk Management.

Endocrine Society. (2022). Adrenal hormones.

French, B., et al. (2023). Risks associated with undiagnosed ADHD and/or autism: A mixed-method systematic review. Journal of Attention Disorders.

Fu, D., et al. (2021). The mechanism, clinical efficacy, safety, and dosage regimen of atomoxetine for adhd therapy in children: A narrative review. Frontiers in Psychiatry.

National Center for Biotechnology Information (2024). PubChem compound summary for CID 54841, Atomoxetine. National Library of Medicine.

Neuchat, E. E., et al. (2023). The role of alpha-2 agonists for attention deficit hyperactivity disorder in children: A review. Neurology International.

Salgado, S., et al. (2015). The nucleus accumbens: A comprehensive review. Stereotactic and Functional Neurosurgery.

Spencer, T. J., et al. (2007). Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment. Journal Articles: Psychiatry.

Upadhyaya, H., et al. (2015). Time-to-onset and -resolution of adverse events before/after atomoxetine discontinuation in adult patients with ADHD. Postgraduate Medicine.

Wernicke, J. F., et al. (2004). Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: A prospective, placebo-controlled assessment. Journal of Clinical Psychopharmacology.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?

Habits for a Healthier Mind

Sign up for our GoodRx Mental Well-being Newsletter to receive up-to-date information on the latest medications, tips, and savings that are most relevant to you.

By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.

Related Articles

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.